QTNTQ Stock Message Board Quotient Limited

This number is not provided by FINRA but we calculate it by subtracting the “Exempt” from the “Short Volume”FINRA Exempt VolumeNumber of short shares sold that were exempt from the uptick rule. This number is included in both the “Short Volume” and “Total Volume” numbers. According to our research, QTNT stock is a bad long-term investment. QTNT share price has been in a bear cycle for the past year. AAII’s A+ Investor Quality Grade comes from the ranking of key metrics. The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

• Companies Marketcap displays them for editorial purposes only.
• It does not include data from other brokers or dark pools.
• Building on over 30 years of experience in transfusion diagnostics, Quotient is a commercial-stage diagnostics company committed to delivering solutions that reshape the way diagnostics is practiced.
• % change compared to the prior day closing price) with a volume of 5.62M shares and market capitalization of 1.34M.

When you buy a stock at close or above 52-week high, you will have one question in mind. But if you compare previous highs with 52 week high, you will get a reasonable idea of what to expect next. This section lists the lowest weeks for Quotient Limited stock.

Quotient Limited – Ordinary Shares (QTNT) Company Bio

It does not include data from other brokers or dark pools. It is a small sample, and it is useful for tracking the rise and fall in demand for shares throughout the day and weeks. It should not be treated as an absolute number of shares that are available to short in the market.

There are not analysts providing consensus earnings estimates for the current fiscal year. Quotient is developing its proprietary MosaiQ TM technology platform to offer a breadth of tests that is unmatched by any commercially available transfusion diagnostic instrument platform. The company’s operations are based in Edinburgh, Scotland; Newtown, Pennsylvania; and Eysins, Switzerland. JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). The value of T-bills fluctuate and investors may receive more or less than their original investments if sold prior to maturity.

Short Sale Data

When you enable T-Bill investing on the Public platform, you open a separate brokerage account with JSI (the “Treasury Account“). The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction. Live educational sessions using site features to explore today’s markets. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Finzoomers Services Private Limited (“Finzoomers”) carries out the business of referrer, intermediary, and facilitation, for varied financial services, including solicitation of insurance policies as a Corporate Agent. Finzoomers got registered with IRDAI as Corporate Agent vide registration no.

In such case, the below table will give some idea of how much further the stock can fall further. Analysts like Quotient more than other Medical companies. The consensus rating for Quotient is Moderate Buy while the average consensus rating for medical companies is Buy. Sign-up to receive the latest news and ratings for QTNT and its competitors with MarketBeat’s FREE daily newsletter. It is not the total number of shares available to short, nor is it the short interest.

Quotient Stock Rating

It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. Quotient Ltd share price live 0.059, this page displays OTC QTNTQ stock exchange data. View the QTNTQ premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Quotient Ltd real time stock price chart below. You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the QTNTQ quote.

% change compared to the prior day closing price) with a volume of 5.62M shares and market capitalization of 1.34M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 439 people.

T-bills are subject to price change and availability – yield is subject to change. Past performance is not indicative of future performance. Investments in T-bills involve a variety of risks, including credit risk, interest rate risk, and liquidity risk. As a general rule, the price of a T-bills moves inversely to changes in interest rates.

We cover only stocks and ETFs listed on NYSE, NASDAQ, and AMEX. The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium. Quotient Limited has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%. This section shows how the previous lows compare with 52-week lowest price.

how company stocks move during an acquisition, Quotient’s proprietary multiplex microarray technology, offers the world’s first fully automated, consolidated testing platform, allowing for multiple tests across different modalities. MosaiQ is designed to be a game-changing solution, which Quotient believes will increase efficiencies, improve clinical practice, deliver significant workflow improvements, and operational cost savings to laboratories around the world. In response to the global effort to combat COVID-19, Quotient developed the MosaiQ COVID-19 Antibody Microarray which is CE marked and has received the U.S. Quotient’s operations are based in Eysins, Switzerland, Edinburgh, Scotland and Newtown, Pennsylvania. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

One strategy is to compare the https://1investing.in/ price against 52 week-high and low. According to analysts, Quotient’s stock has a predicted upside of 517.24% based on their 12-month price targets. This data is the official short interest data, as provided by NASDAQ. Short Interest is the total number of open short positions of a security. Note that the Float and Short Interest % Float provided in the table is the data as of the settlement date. For daily updates, see the Short Interest % Floatblock above.

Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, national and international news to professionals via desktop terminals, the world’s media organizations, industry events and directly to consumers. Assume the stock you hold is trading close or below to 52 week low.

This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured. Apex Clearing Corporation, our clearing firm, has additional insurance coverage in excess of the regular SIPC limits. We present 13D/G filings separately from the 13F filings because of the different treatement by the SEC. 13D/G filings can be filed by groups of investors , whereas 13F filings cannot.

As of , had a $0.0 market capitalization, putting it in the percentile of companies in the industry. Learn more about whether is a good stock to buy or sell based on recent news as well as its key financial metrics. Read on to find out how () grades on certain investment factors and determine whether it meets your investment needs. To see all exchange delays and terms of use, please see disclaimer. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted.